IgA Nephropathy (IgAN) Completed Phase 4 Trials for Valsartan (DB00177)

Back to IgA Nephropathy (IgAN)

Also known as: IgAN - IgA Nephropathy / Nephropathy, IGA / IgA Nephropathy / Glomerulonephritis focal / Primary IgA nephropathy (disorder) / Berger's disease / Glomerulonephritis, IGA / IgA nephropathy (disorder)

Indication	Status	Phase
DBCOND0050148 (IgA Nephropathy (IgAN))	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00426348	A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy	Treatment	Probucol (DB01599) Valsartan (DB00177)
NCT00367562	Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy	Treatment	Enalapril (DB00584) Methylprednisone (DB12952) Valsartan (DB00177)